SANUWAVE Health, Inc.  

(Public, OTCBB:SNWV)   Watch this stock  
Find more results for SNWV)
+0.005 (1.22%)
After Hours: 0.400 -0.015 (-3.61%)
Aug 27, 4:00PM EDT  
OTCBB data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.40 - 0.41
52 week 0.35 - 0.82
Open 0.40
Vol / Avg. 37,000.00/53,140.00
Mkt cap 21.04M
P/E     -
Div/yield     -
EPS -0.27
Shares 50.71M
Beta 145.34
Inst. own 31%
Aug 7, 2014
Q2 2014 SANUWAVE Health Inc Earnings Call
Aug 6, 2014
Q2 2014 SANUWAVE Health Inc Earnings Release

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -711.26% -1494.29%
Operating margin -678.14% -1177.88%
EBITD margin - -706.18%
Return on average assets -85.24% -695.33%
Return on average equity -492.38% -
Employees 11 -
CDP Score - -


Suite 150, 11475 Great Oaks Way
United States - Map
+1-678-5816843 (Phone)
+1-770-4198634 (Fax)

Website links


SANUWAVE Health, Inc. is a regenerative medicine company focused on the development and commercialization of noninvasive, biological response activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's portfolio of products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration.The Company is focused on developing its Pulsed Acoustic Cellular Expression (PACE) technology to activate healing in wound conditions, including diabetic foot ulcers, venous ulcers, pressure sores, burns and other skin eruption conditions; orthopedic/spine applications.

Officers and directors

Kevin A. Richardson II Chairman of the Board, Co-Chief Executive Officer
Age: 45
Barry J. Jenkins Chief Financial Officer, Chief Operating Officer
Age: 50
John F. Nemelka Director
Age: 48
Alan L. Rubino Director
Age: 59